CARA - Cara Therapeutics, Inc.
IEX Last Trade
0.4316
-0.008 -1.946%
Share volume: 13,965
Last Updated: Thu 26 Dec 2024 08:28:32 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$0.44
-0.01
-1.91%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-07 | 2023-03-06 | 2023-05-15 | 2023-08-07 | 2023-11-13 | 2024-03-06 | 2024-05-13 | |
| Total revenue | 23.003 M | 10.813 M | 3.261 M | 6.165 M | 6.933 M | 4.866 M | 3.004 M | 2.135 M | |
| Cost of revenue | 0.000 | 3.055 M | 2.130 M | 2.590 M | 1.418 M | 1.558 M | 608.000 K | 620.000 K | |
| Gross profit | 23.003 M | 7.758 M | 1.131 M | 3.575 M | 5.515 M | 3.308 M | 2.396 M | 1.515 M | |
| -66.27% | -85.42% | 216.09% | 54.27% | -40.02% | -27.57% | -36.77% | |||
| Operating expenses | 24.730 M | 29.915 M | 40.523 M | 29.502 M | 35.945 M | 32.206 M | 38.636 M | 28.780 M | |
| Selling general and admin | 4.825 M | 5.224 M | 14.513 M | 5.168 M | 5.635 M | 6.755 M | 10.221 M | 6.816 M | |
| Research and development | 19.905 M | 24.691 M | 26.010 M | 24.334 M | 30.310 M | 25.451 M | 28.415 M | 21.964 M | |
| Total expenses | 27.475 M | 34.658 M | 34.568 M | 33.815 M | 39.273 M | 33.764 M | 35.611 M | 29.400 M | |
| 26.14% | -0.26% | -2.18% | 16.14% | -14.03% | 5.47% | -17.44% | |||
| Operating income | -4.472 M | -23.845 M | -31.307 M | -27.650 M | -32.340 M | -28.898 M | -32.607 M | -27.265 M | |
| Ebit | -4.472 M | -23.845 M | -31.307 M | -27.650 M | -32.340 M | -28.898 M | -32.607 M | -27.265 M | |
| Pretax income | -4.206 M | -23.180 M | -30.339 M | -26.665 M | -31.479 M | -28.032 M | -32.337 M | -30.696 M | |
| 451.12% | 30.88% | -12.11% | 18.05% | -10.95% | 15.36% | -5.07% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -4.206 M | -23.180 M | -30.339 M | -26.665 M | -31.479 M | -28.032 M | -32.337 M | -30.696 M | |
| -451.12% | -30.88% | 12.11% | -18.05% | 10.95% | -15.36% | 5.07% | |||
| Net income | -4.206 M | -23.180 M | -30.339 M | -26.665 M | -31.479 M | -28.032 M | -32.337 M | -30.696 M | |
| -451.12% | -30.88% | 12.11% | -18.05% | 10.95% | -15.36% | 5.07% |